TITCK (Turkey) Updates
The latest guidances, approvals, and safety alerts from TITCK (Turkey), curated by automated regulatory intelligence.
Public notice indicating that the regulator has issued an announcement (“DUYURU”) referenced by the number 5404.
Informs biocidal firms about an official TITCK notice numbered 5403. The provided excerpt contains only the announcement header (“Duyuru”) and does not specify…
Publishes a notice conveying the institution leadership’s message for 10 November—Atatürk Commemoration Day.
Safety contact points for pharmacovigilance are being referenced/announced by TITCK, indicating that companies should ensure their pharmacovigilance…
Establishes a draft framework on how clinical trial parties should handle and report safety notifications during clinical research.
Financial statements for July 2026 are announced, referencing document number 5400.
Explains how TITCK’s Module (e.g., “Klinik Araştırmalar Modülü”) list of investigational products should be used by clinical research stakeholders.
Updates a communication and information-sharing guideline under identifier KYS-KLVZ-01 (topic number 5398), signaling an administrative change to how…
MDCG 2026-4 Rev.1 announces TITCK/EUDAMED expectations for how manufacturers should manage SS(C)P within the EUDAMED system.
Financial statements notice related to September 2026 under Law No. 5396. Provides a public announcement framework regarding the submission/availability of the…
Announces the availability of August 2026 financial statements related to “5395.” Regulatory professionals should confirm whether any submission, publication…
Public notice (announcement) titled “5394” provides information intended for the general public.
Public notice titled “5393” with no substantive regulatory text provided in the supplied excerpt.
Provides a draft framework for clinical trial applications submitted to the Turkish Medicines and Medical Devices Agency (TITCK) and for applications submitted…
Provides an information/implementation pathway for importers authorized by foreign manufacturers to upload the manufacturer’s declaration of conformity, the…
Establishes an announcement related to the European Pharmacopoeia 3DP Working Group (5390).
Publishes a formal Republic Day (29 October) message from the Head of TİTCK, serving as an informational/communications notice rather than a regulatory policy…
Sets expectations regarding training and competency certification for the “human medicinal product promotion representative” role, through a TITCK…
Announces an information/training-related notice regarding a “Cosmetics Product Safety Evaluator Training” program associated with TİTCK.
Announces the existence of a guide regarding the pricing of medicinal products for human use.